Read all posts

Beta-Blockers: No Broad Benefit in Stable Heart Disease?

Beta-blockers might reduce the risk of death or a repeat event in the first years after a heart attack but not in other newly-diagnosed heart disease, an observational study suggested. The risk of mortality or myocardial infarction (MI) came in 9% lower and the risk of death 10% lower over 3.7 years of follow-up among beta-blocker users versus nonusers after controlling for other factors, Mark A.

Read the article on Medpagetoday

Dr. Sears Comments:

Dr. Barry Sears

When some researcher suggests possible harm from a billion-dollar-a-year class of drugs, you can imagine some in the medical community will complain as opposed to doing more studies to confirm or disprove the initial findings. I think this is called science.

Leave a Reply

Your email address will not be published. Required fields are marked *